The Infectious Diseases Society of America, for the first time, developed guidelines for the management of three groups of antimicrobial resistant gram-negative bacteria, which pose particular therapeutic challenges. This webinar summarizes the resistance among these pathogens, and discusses the new guideline recommendations and the role of new agents developed in clinical practice. Learn more about Associate Professor Warren Rose's work at apps.pharmacy.wisc.edu/sopdir...
This program was organized by the Office of Advancement at the School of Pharmacy.